EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Applications and latest research progress of liposomes in the treatment of ocular diseases

Huan Tang, Xinnan Li iD, Lin Jin iD, Jicheng Dong, Li Yang, Chunmei Li iD, Lijun Zhang iD, Fang Cheng iD

Biointerphases · 01.01.2025 · 20 (1)

DOI: 10.1116/6.0004159 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Biointerphases, online erschienen am 09.01.2025. Verfasst von Huan Tang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116081, China. Hauptthemen laut MEDLINE: Liposomes, Eye Diseases. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 191 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Dalian Science and Technology Innovation Fund, Liaoning Provincial Basic Applied Research Program.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The special structure of eyes and the existence of various physiological barriers make ocular drug delivery one of the most difficult problems in the pharmaceutical field. Considering the problems of patient compliance, local administration remains the preferred method of drug administration in the anterior part of eyes. However, local administration suffers from poor bioavailability, need for frequent administration, and systemic toxicity. Administration in the posterior part of the eye is more difficult, and intravitreal injection is often used. But intravitreal injection faces the problems of poor patient compliance and likely side effects after multiple injections. The development of nanocarrier technology provides an effective way to solve these problems. Among them, liposomes, as the most widely used carrier in clinical application, have the characteristics of amphiphilic nanostructure, easy surface modification, extended release time, good biocompatibility, etc. The liposomes are expected to overcome obstacles and effectively deliver drugs to the target site to improve ocular drug bioavailability. This review summarized the various controllable properties of liposomes for ocular delivery as well as the application and research progress of liposomes in various ocular diseases. In addition, we summarized the physiological barriers and routes of administration contained in eyes, as well as the prospects of liposomes in the treatment of ocular diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LiposomesEye DiseasesHumansDrug Delivery SystemsAnimalsBiological Availability

Substanzen

Liposomes

Autor:innen und Institutionen

  • Faculty of Medicine, Dalian University of Technology, Dalian, Liaoning 116081, China.
  • Department of Ophthalmology, The Third People's Hospital of Dalian, Dalian, Liaoning 116091, China.
  • Department of Pharmaceutical Sciences, State Key Laboratory of Fine Chemicals, School of Chemical Engineering, Dalian University of Technology, Dalian, Liaoning 116081, China.
  • Tsinghua International School Daoxiang Lake, Beijing 100194, China.
  • Ningbo Institute of Dalian University of Technology, Ningbo, Zhejiang 315032, China.

ORCID-Profile: Xinnan Li, Lin Jin, Chunmei Li, Lijun Zhang, Fang Cheng

Förderung

  • National Natural Science Foundation of China
  • Dalian Science and Technology Innovation Fund
  • Liaoning Provincial Basic Applied Research Program
  • Fundamental Research Funds for the Central Universities
  • Science Research Projects of The Third People's Hospital of Dalian

Zitieren

APA

Tang, H., Li, X., Jin, L., Dong, J., Yang, L., Li, C., Zhang, L., & Cheng, F. (2025). Applications and latest research progress of liposomes in the treatment of ocular diseases. Biointerphases, 20(1). https://doi.org/10.1116/6.0004159

Vancouver

Tang H, Li X, Jin L, Dong J, Yang L, Li C, et al. Applications and latest research progress of liposomes in the treatment of ocular diseases. Biointerphases. 2025;20(1). doi:10.1116/6.0004159

BibTeX
@article{Tang2025,
  author = {Tang, Huan and Li, Xinnan and Jin, Lin and Dong, Jicheng and Yang, Li and Li, Chunmei and Zhang, Lijun and Cheng, Fang},
  title = {Applications and latest research progress of liposomes in the treatment of ocular diseases},
  journal = {Biointerphases},
  year = {2025},
  volume = {20},
  number = {1},
  doi = {10.1116/6.0004159}
}
Kostenlos starten →